ProQR Therapeutics (PRQR) Net Cash Flow Growth (5y) (2018 - 2026)
ProQR Therapeutics (PRQR) Net Cash Flow Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 181.75 Mn | 89.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.26% |
| Dec 31, 2025 | -7.49% |
| Sep 30, 2025 | -43.29% |
| Jun 30, 2025 | -3.61% |
| Mar 31, 2025 | -310.62% |
| Dec 31, 2024 | 8.30% |
| Sep 30, 2024 | 25.92% |
| Jun 30, 2024 | 7.83% |
| Mar 31, 2024 | -22.41% |
| Dec 31, 2023 | 112.35% |
| Sep 30, 2023 | -15.86% |
| Jun 30, 2023 | -11.53% |
| Mar 31, 2023 | 920.60% |
| Dec 31, 2022 | -162.08% |
| Sep 30, 2022 | -1,616.67% |
| Jun 30, 2022 | -6.89% |
| Mar 31, 2022 | -333.35% |
| Dec 31, 2021 | 21.75% |
| Sep 30, 2021 | 304.27% |
| Dec 31, 2020 | 17.86% |